Risedronate sodium
Drug ingredientCAS 115436-72-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
12 FDA-registered drug labelers
Alchymars ICM SM Private Limited
Apotex Corp.
Aurobindo Pharma Limited
Cipla Ltd.
Hetero Drugs Limited
Jubilant Biosys limited
Macleods Pharmaceuticals Limited
Proficient Rx LP
Sun Pharmaceutical Industires Inc.
SUN PHARMACEUTICAL INDUSTRIES, INC.
Synthimed Labs Private Limited
TAPI Croatia Industries Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Risedronate Sodium
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS115436-72-1
PubChem CID4194514
DTXSIDDTXSID1046132
FormulaC7H10NNaO7P2
Mol. Weight305.09 g/mol
SMILESC1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]
Data Sources
- PubChem · compound 4194514Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Risedronate sodium (CAS 115436-72-1) https://chemicalindependence.com/chemical/115436-72-1/ PubChem: 4194514. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/4194514 FDA National Drug Code directory: CAS 115436-72-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/